COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Cosmos Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026
$0.33−0.01 (-1.90%)
Close on Oct 19, 2026
- Market cap
- $19.48M
- P/E (TTM)
- –
- Dividend yield
- –
Cosmos Health Inc. revenue by segment
By business segment
| Revenue | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 23 | Q3 23 | Q2 23 | Q4 22 | Q3 22 | Q2 22 | Q3 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wholesale [Member] | $16.89M | $18.71M | $14.57M | $13.53M | $12.50M | $15.84M | $11.94M | – | – | – | – | – | 94.2% | +35.1% |
| Nutraceuticals and Pharmaceuticals [Member] | $796.31K | $516.52K | $2.12M | $684.11K | $939.41K | – | $796.58K | – | – | – | – | – | 4.4% | -15.2% |
| Pharma manufacturing [Member] | $238.20K | $475.50K | $412.60K | $532.40K | $268.56K | $253.65K | $91.06K | – | – | – | – | – | 1.3% | -11.3% |
| Other [Member] | $485 | $823 | $405 | $0 | $0 | – | – | – | – | – | – | – | 0.0% | – |
| Total Segment [Member] | – | – | $17.11M | $14.75M | $13.71M | – | – | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 23 | Q3 23 | Q2 23 | Q4 22 | Q3 22 | Q2 22 | Q3 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Greece [Member] | – | – | – | – | – | – | – | – | – | – | – | $13.56M | – | – |
| Croatia [Member] | – | – | – | – | – | – | – | – | – | – | – | $3.11K | – | – |
| UK [Member] | – | – | – | – | – | – | $190.61K | $745.66K | – | $26.21K | $40.83K | – | – | – |
| Greece [Member] | – | – | – | – | – | – | $12.54M | $11.58M | – | $11.99M | $13.15M | – | – | – |
| Cyprus [Member] | – | – | – | – | – | – | $72.75K | $35.33K | – | $0 | $0 | – | – | – |
| USA [Member] | – | – | – | – | – | – | – | $294 | – | – | $0 | – | – | – |
| Croatia [Member] | – | – | – | – | – | – | $14.16K | $0 | – | -$710 | $15.42K | – | – | – |
| Ireland | – | – | – | – | – | – | $1.42K | – | – | $0 | – | – | – | – |
| US [Member] | – | – | – | – | – | – | $210 | – | – | $0 | – | – | – | – |
From the segment and revenue-disaggregation notes of Cosmos Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.